Alzheimer’s Drug Study Yields Mixed Results. Wall Street Still Likes Axsome.
In one study, the company’s drug eased the agitation for Alzheimer’s patients. In a different study, there wasn’t a ...
Worcester Telegram on MSN5d
MA lawmakers send Healey bill to cap some drug costs, regulate pharmacy benefit mangers
Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, and face no costs for ...
In a late scramble, state lawmakers send health care bills on Steward collapse and drug costs to Healey
The legislative rush provided another example of state lawmakers struggling to reach consensus on significant policy matters, ...
Drug overdose deaths plummet in San Francisco. What’s changed?
Drug overdose deaths fell sharply in San Francisco in 2024. Experts credit better access to overdose-reversal medication and ...
ScienceAlert on MSN4d
Common ADHD Drug Could Make Some People Better Drivers
Adults with ADHD are more at risk for road accidents, motor vehicle injuries, traffic tickets, and hard braking events.
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
Elon Musk admits to taking controversial weight loss drug previously opposed by RFK Jr.
Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
The Healthy on MSN3d
FDA Announcement: The First Generic GLP-1 Shot Has Just Been Approved
This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
CNN12d
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic. Both are sold by Danish drug giant Novo ...
devdiscourse3d
Veeda Lifesciences: Innovating Drug Development with a Revitalized Brand Identity
Veeda Group has rebranded to Veeda Lifesciences, reflecting its evolution into a drug development enterprise. It comprises four strategic units: Clinical Trials, Healthy Volunteer Services, Biopharma ...